Phyto Chem (I)

  • Market Cap: Micro Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE037C01010
  • NSEID:
  • BSEID: 524808
INR
26.00
-1.75 (-6.31%)
BSENSE

Jun 02

BSE+NSE Vol: 2.56 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.56 k (-53.12%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.19%

Held by 0 DIIs

Promoter

40.40%

Who are the top shareholders of the Phyto Chem (I)?

06-Jun-2025

The top shareholder of Phyto Chem (I) is promoter Nayudamma Yarlagadda, holding 7.87%. Individual investors own 49.29% of the shares, with no pledged promoter holdings or foreign institutional investors involved.

The top shareholders of Phyto Chem (I) include Nayudamma Yarlagadda, who is the promoter with the highest holding at 7.87%. The majority of the shareholding is held by individual investors, accounting for 49.29% of the shares. There are no pledged promoter holdings, and the company has no foreign institutional investors (FIIs) involved. Additionally, two mutual fund schemes hold a small portion of shares, totaling 0.19%.

View full answer

What does Phyto Chem (I) do?

06-Jun-2025

Phyto Chem (India) Ltd manufactures and markets pesticides for the agriculture sector. As of March 2025, it reported net sales of 1 Cr and a net loss of 1 Cr, with a market cap of Rs 12 Cr.

Overview: <BR>Phyto Chem (India) Ltd is engaged in the manufacturing and marketing of pesticides for the agriculture sector and operates within the Micro Cap category in the Pesticides & Agrochemicals industry.<BR><BR>History: <BR>Established in January 1989, Phyto Chem (India) Ltd has been involved in the pesticides business since its inception. The latest quarterly results reported are for March 2025, showing net sales and profit figures.<BR><BR>Financial Snapshot: <BR>Net Sales: 1 Cr (Quarterly Results - Mar 2025) <BR>Net Profit: -1 Cr (Quarterly Results - Mar 2025) <BR>Market Cap: Rs 12 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 38 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 2.45 <BR>Return on Equity: -13.59% <BR>Price to Book: 1.65<BR><BR>Contact Details: <BR>Address: Survey No 628 Temple Street, Jinnaram Mandal Bonthapally Medak Telangana : 502313 <BR>Tel: 91-8458-275236 <BR>Email: info@phytochemindia.com <BR>Website: http://www.phytochemindia.com

View full answer

Who are in the management team of Phyto Chem (I)?

06-Jun-2025

As of March 2022, the management team of Phyto Chem (I) includes Chairman P Sreemannarayana, Managing Director Y Nayudamma, and several directors, including both executive and independent members, totaling twelve key individuals.

As of March 2022, the management team of Phyto Chem (I) includes the following members:<BR><BR>1. P Sreemannarayana - Chairman (Non-Executive)<BR>2. Y Nayudamma - Managing Director<BR>3. Y Venkateswarlu - Director<BR>4. P Anjaneyulu - Director<BR>5. Y Janaki Ramaiah - Executive Director<BR>6. Pavansingh Thakur - Company Secretary & Compliance Officer<BR>7. M Sreerama Murthy - Independent Director<BR>8. G S R Anjaneyulu - Independent Director<BR>9. Yugandhar Sampath Kumar Sakhamuri - Independent Director<BR>10. Vijitha Gorrepati - Independent Director<BR>11. K. Srinivasa Rao - Alternate Director<BR>12. N. Nagendra Naidu - Independent Director<BR><BR>This team comprises a mix of executive, non-executive, and independent directors, contributing to the governance and strategic direction of the company.

View full answer

Has Phyto Chem (I) declared dividend?

06-Jun-2025

Phyto Chem (India) Ltd has declared a 10% dividend, amounting to ₹1.00 per share, with an ex-date of September 25, 2014. However, the dividend yield is 0%, and total returns over recent periods have been largely negative, except for the 3-year and 4-year spans.

Phyto Chem (India) Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1.0000<BR>- Ex-date: 25 Sep 14<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -22.7%, the dividend return was 0%, resulting in a total return of -22.7%.<BR><BR>For the 1-year period, the price return was -8.67%, the dividend return was 0%, leading to a total return of -8.67%.<BR><BR>Over the 2-year period, the price return was -21.4%, with a dividend return of 0%, resulting in a total return of -21.4%.<BR><BR>In the 3-year period, the price return was 29.15%, the dividend return was 0%, which resulted in a total return of 29.15%.<BR><BR>For the 4-year period, the price return was 22.81%, the dividend return was 0%, leading to a total return of 22.81%.<BR><BR>In the 5-year period, the price return was -4.81%, with a dividend return of 0%, resulting in a total return of -4.81%.<BR><BR>Overall, while Phyto Chem (India) Ltd has declared a dividend, the total returns over various periods show significant fluctuations, with negative returns in most periods except for the 3-year and 4-year spans. The dividend yield remains at 0%, indicating that the dividend has not contributed to the overall returns in recent years.

View full answer

Who are the peers of the Phyto Chem (I)?

03-Jun-2025

Phyto Chem (I) peers include P I Industries, UPL, Bayer CropSci., and others, with varying management and growth risks. Sharda Cropchem leads in 1-year returns at 102.43%, while Phyto Chem (I) has a return of -9.03%.

Peers: The peers of Phyto Chem (I) are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., and Bharat Rasayan.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and the rest. Good management risk is found at P I Industries, Sumitomo Chemi., Sharda Cropchem, and Bharat Rasayan, while Average management risk is present at UPL, Rallis India, and Bhagiradha Chem. In terms of growth, Excellent growth is seen at P I Industries, while Below Average growth is noted at UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, Rallis India, Bhagiradha Chem., and Bharat Rasayan. Capital Structure is Excellent for P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Sharda Cropchem, and Bharat Rasayan, while Good capital structure is found at Bhagiradha Chem., and Below Average at UPL, Rallis India, and Phyto Chem (I).<BR><BR>Return Snapshot: The peer with the highest 1-year return is Sharda Cropchem at 102.43%, while Bharat Rasayan has the lowest at -12.17%. Phyto Chem (I) has a 1-year return of -9.03%, which is higher than Bharat Rasayan's but lower than Sharda Cropchem's. Additionally, UPL, Bharat Rasayan, and Phyto Chem (I) have negative six-month returns.

View full answer

Is Phyto Chem (I) overvalued or undervalued?

09-Jun-2025

As of May 30, 2024, Phyto Chem (I) is considered risky and overvalued, with poor financial ratios indicating negative earnings performance and significant underperformance compared to industry peers and the Sensex.

As of 30 May 2024, the valuation grade for Phyto Chem (I) has moved from attractive to risky, indicating a significant deterioration in its financial standing. The company is currently assessed as overvalued. Key ratios reveal a PE ratio of -12.21, an EV to EBITDA of -22.40, and a ROE of -13.59%, all of which suggest poor profitability and negative earnings performance.<BR><BR>In comparison to its peers, Phyto Chem (I) stands out unfavorably; for instance, P I Industries has a PE ratio of 35.59, while UPL boasts a PE ratio of 38.74, both indicating a much stronger valuation. The negative ratios and the shift in valuation grade highlight that Phyto Chem (I) is not only underperforming relative to its industry peers but also reflects a concerning trend in its financial health. Additionally, the company's stock has underperformed the Sensex over various time frames, including a year-to-date decline of 17.85% compared to the Sensex's gain of 5.63%.

View full answer

What is the technical trend for Phyto Chem (I)?

09-Jun-2025

As of May 27, 2025, Phyto Chem (I) has a bearish technical trend, supported by negative MACD indicators and moving averages, while the RSI shows no momentum and Dow Theory indicates no clear trend.

As of 27 May 2025, the technical trend for Phyto Chem (I) has changed from mildly bearish to bearish. The weekly and monthly MACD indicators are both bearish, reinforcing the negative sentiment. The daily moving averages also indicate a bearish stance. Although the Bollinger Bands show a mildly bearish trend on both weekly and monthly time frames, the KST is bearish as well. The RSI shows no signal, indicating a lack of momentum in either direction. Dow Theory confirms no trend on both weekly and monthly levels. Overall, the current technical stance is bearish with a moderate strength, driven primarily by the bearish MACD and moving averages.

View full answer

How big is Phyto Chem (I)?

24-Jul-2025

As of 24th July, Phyto Chem (India) Ltd has a market capitalization of 13.00 Cr, with recent net sales of 14.09 Cr and a net profit loss of 1.00 Cr over the last four quarters. Shareholder's funds are 7.36 Cr, and total assets are valued at 31.17 Cr.

As of 24th July, <BR><BR>Market Cap: Phyto Chem (India) Ltd has a market capitalization of 13.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 14.09 Cr, while the sum of Net Profit for the same period reflects a loss of 1.00 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period for the latest annual data is March 2024. Shareholder's Funds stand at 7.36 Cr, and Total Assets are valued at 31.17 Cr.

View full answer

When is the next results date for Phyto Chem (I)?

07-Nov-2025

Phyto Chem (I) will announce its results on 14 November 2025.

Phyto Chem (I) will declare its results on 14 November 2025.

View full answer

How has been the historical performance of Phyto Chem (I)?

01-Dec-2025

Phyto Chem (I) has shown a declining trend in net sales and profitability, with net sales dropping from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25, resulting in significant losses and negative operating profit. The company's financial health has deteriorated, reflected in increasing losses and stagnant cash flow.

Answer:<BR>The historical performance of Phyto Chem (I) shows a declining trend in net sales and profitability over the years, with significant losses reported in the most recent fiscal year.<BR><BR>Breakdown:<BR>Phyto Chem (I) has experienced a consistent decline in net sales, dropping from 44.49 Cr in Mar'21 to just 14.08 Cr in Mar'25. This decline is mirrored in total operating income, which also fell from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25. The company's total expenditure has decreased from 42.28 Cr in Mar'21 to 15.42 Cr in Mar'25, yet it remains higher than the operating income, resulting in an operating profit (PBDIT) that has turned negative, reaching -1.34 Cr in Mar'25. Profit before tax has similarly worsened, moving from a profit of 0.47 Cr in Mar'21 to a loss of 1.05 Cr in Mar'25, leading to a profit after tax of -0.99 Cr for the same period. The earnings per share have also deteriorated, showing a loss of -2.3 in Mar'25 compared to a profit of 1.14 in Mar'21. On the balance sheet, total liabilities have decreased from 67.59 Cr in Mar'20 to 27.30 Cr in Mar'25, while total assets have similarly declined from 67.59 Cr to 27.30 Cr over the same period. The company has reported no cash inflow or outflow in recent years, indicating a stagnant cash position. Overall, Phyto Chem (I) has faced significant challenges, reflected in its declining sales, increasing losses, and deteriorating financial health.

View full answer

Are Phyto Chem (India) Ltd latest results good or bad?

02-Jun-2026

Phyto Chem (India) Ltd's latest results are concerning, showing a net loss of ₹0.28 crores for Q4 FY26, with revenue plummeting 84.25% year-over-year and 92.26% from the previous quarter. The company faces significant operational challenges, reflected in a negative operating margin and return on equity, indicating a negative outlook.

The latest results for Phyto Chem (India) Ltd are quite concerning. In the fourth quarter of FY26, the company reported a net loss of ₹0.28 crores, marking its fourth consecutive quarter of losses. Revenue has drastically declined to ₹0.23 crores, which represents an alarming 84.25% decrease compared to the same quarter last year and a staggering 92.26% drop from the previous quarter.<BR><BR>The operating margin is severely negative at -282.61%, indicating that the company's fixed costs far exceed its revenue generation capacity. Additionally, the return on equity (ROE) stands at -50.00%, reflecting significant capital destruction and raising serious questions about the sustainability of its business model.<BR><BR>Overall, these results paint a grim picture of a company in distress, struggling to maintain operational viability in a challenging market environment. The combination of collapsing revenue, mounting losses, and negative profitability metrics suggests that the outlook for Phyto Chem is quite negative at this time.

View full answer

Should I buy, sell or hold Phyto Chem (India) Ltd?

03-Jun-2026

Why is Phyto Chem (India) Ltd falling/rising?

03-Jun-2026

As of 02-Jun, Phyto Chem (India) Ltd's stock price is Rs 26.00, down 6.31% after a trend reversal. The stock has shown significant volatility and underperformed its sector, reflecting negative investor sentiment despite trading above some moving averages.

As of 02-Jun, Phyto Chem (India) Ltd's stock price is falling, currently at Rs 26.00, which reflects a decrease of Rs 1.75 or 6.31%. This decline follows a trend reversal after five consecutive days of gains. The stock has underperformed its sector by 6.49% today and has experienced significant volatility, with an intraday volatility of 6.2%. <BR><BR>Additionally, the stock touched an intraday low of Rs 24.5, marking a drop of 11.71%. Despite having higher trading volumes close to this low price, the overall performance today indicates a negative sentiment among investors. The stock's year-to-date performance shows a decline of 8.61%, which is less severe than the Sensex's drop of 12.40%, but it still reflects a challenging environment for the stock. <BR><BR>Moreover, while the stock is trading above its 20-day, 50-day, and 100-day moving averages, it is below its 5-day and 200-day moving averages, suggesting mixed signals regarding its short-term and long-term trends. Overall, these factors contribute to the stock's current downward movement.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -24.53% and Operating profit at -205.28% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) of 2.33 times
  • The company has been able to generate a Return on Equity (avg) of 1.88% signifying low profitability per unit of shareholders funds
2

Flat results in Mar 26

3

Risky - Negative EBITDA

4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 12 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

29

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.75

stock-summary
Return on Equity

-50.00%

stock-summary
Price to Book

2.27

Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Mar 2026)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.34%
0%
6.34%
6 Months
-16.07%
0%
-16.07%
1 Year
-8.26%
0%
-8.26%
2 Years
-19.98%
0%
-19.98%
3 Years
-25.95%
0%
-25.95%
4 Years
34.37%
0%
34.37%
5 Years
13.04%
0%
13.04%

Latest dividend: 1.0000 per share ex-dividend date: Sep-25-2014

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

30-May-2026 | Source : BSE

Pursuant to Regulation 47 of the SEBI (LODR) regulation 2015 please find enclosed copies of the newspaper advertisement pertaining Audited Financial Results of the Company for the Quarter and Year ended March 31 2026. The advertisements were published in Business Standard (English) and Andhra Prabha (Telugu) on May 30 2026.

Compliances-Reg.24(A)-Annual Secretarial Compliance

30-May-2026 | Source : BSE

Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 08 2019 please find attached Annual Secretarial Compliance Report of Phyto Chem (India) Limited for the financial year ended March 31 2026.

Results-Financial Results For May 29Th 2026(Submission Of Audited Financial Results Of The Company For The Fourth Quarter & Year Ended 31St March 2026

29-May-2026 | Source : BSE

In furtherance to the Board Meeting Notice dt.22nd May 2026 we wish to inform you that at the meeting of Board of Directors of M/s. Phyto Chem (India) Limited held today i.e. on 29th May 2026 the Board has considered and approved the Audited Financials for the 4th Quarter and year ended 31st March 2026. The said Audited Financial Results were reviewed by the Audit Committee and thereafter approved by the Board. Pursuant to Regulation 33 of the SEBI(LODR) Regulations 2015 statement showing the Audited Financial Results for the 4th Quarter & Year ended 31st March 2026 along with the statement of Assets & Liabilities Cash Flow statement and Auditors Report of the Statutory Auditors are enclosed herewith. Persuant Reg. 33(3)(d) of the SEBI (LODR) Regulation2015 the Board declares the the above said Auditors Reports are with unmodified opinion with respect to the Audited Financial Results for the 4th Quarter & Year ended 31st March 2026.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Phyto Chem (India) Ltd has declared 10% dividend, ex-date: 25 Sep 14

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-27.26%
EBIT Growth (5y)
-204.42%
EBIT to Interest (avg)
-0.52
Debt to EBITDA (avg)
4.65
Net Debt to Equity (avg)
2.75
Sales to Capital Employed (avg)
1.02
Tax Ratio
4.28%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.19%
ROCE (avg)
-2.55%
ROE (avg)
1.88%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
29
Price to Book Value
2.09
EV to EBIT
-11.73
EV to EBITDA
-14.02
EV to Capital Employed
1.29
EV to Sales
2.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-10.79%
ROE (Latest)
-33.58%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.19%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Nayudamma Yarlagadda (7.87%)

Highest Public shareholder

None

Individual Investors Holdings

49.64%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -84.25% vs 224.44% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 75.86% vs 32.16% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.23",
          "val2": "1.46",
          "chgp": "-84.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.65",
          "val2": "-1.05",
          "chgp": "38.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.57",
          "chgp": "-36.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.28",
          "val2": "-1.16",
          "chgp": "75.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-282.61%",
          "val2": "-71.92%",
          "chgp": "-210.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -34.63% vs 14.39% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 23.53% vs 29.17% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.87",
          "val2": "8.98",
          "chgp": "-34.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.96",
          "val2": "-0.46",
          "chgp": "-108.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.67",
          "val2": "0.76",
          "chgp": "-11.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.04",
          "val2": "-1.36",
          "chgp": "23.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-16.35%",
          "val2": "-5.12%",
          "chgp": "-11.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -30.01% vs -12.11% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -1,050.00% vs 109.82% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.84",
          "val2": "12.63",
          "chgp": "-30.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.21",
          "val2": "-0.29",
          "chgp": "-317.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.14",
          "val2": "1.28",
          "chgp": "-10.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.52",
          "val2": "0.16",
          "chgp": "-1,050.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-13.69%",
          "val2": "-2.30%",
          "chgp": "-11.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -35.58% vs -4.93% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -81.82% vs 70.27% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.07",
          "val2": "14.08",
          "chgp": "-35.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.86",
          "val2": "-1.34",
          "chgp": "-38.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.50",
          "val2": "1.84",
          "chgp": "-18.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.80",
          "val2": "-0.99",
          "chgp": "-81.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-20.51%",
          "val2": "-9.52%",
          "chgp": "-10.99%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
0.23
1.46
-84.25%
Operating Profit (PBDIT) excl Other Income
-0.65
-1.05
38.10%
Interest
0.36
0.57
-36.84%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.28
-1.16
75.86%
Operating Profit Margin (Excl OI)
-282.61%
-71.92%
-210.69%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is -84.25% vs 224.44% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 75.86% vs 32.16% in Mar 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
5.87
8.98
-34.63%
Operating Profit (PBDIT) excl Other Income
-0.96
-0.46
-108.70%
Interest
0.67
0.76
-11.84%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.04
-1.36
23.53%
Operating Profit Margin (Excl OI)
-16.35%
-5.12%
-11.23%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -34.63% vs 14.39% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 23.53% vs 29.17% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
8.84
12.63
-30.01%
Operating Profit (PBDIT) excl Other Income
-1.21
-0.29
-317.24%
Interest
1.14
1.28
-10.94%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.52
0.16
-1,050.00%
Operating Profit Margin (Excl OI)
-13.69%
-2.30%
-11.39%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -30.01% vs -12.11% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -1,050.00% vs 109.82% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
9.07
14.08
-35.58%
Operating Profit (PBDIT) excl Other Income
-1.86
-1.34
-38.81%
Interest
1.50
1.84
-18.48%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.80
-0.99
-81.82%
Operating Profit Margin (Excl OI)
-20.51%
-9.52%
-10.99%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -35.58% vs -4.93% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is -81.82% vs 70.27% in Mar 2025

stock-summaryCompany CV
About Phyto Chem (India) Ltd stock-summary
stock-summary
Phyto Chem (India) Ltd
Micro Cap
Pesticides & Agrochemicals
Phyto Chem (India) Limited was established in January, 1989 and is into the business of manufacturing & marketing of pesticides for agriculture sector. The Company is presently carrying on the business in three segments i.e. Pesticides Formulations, Ferro Alloy Products and Real Estate.
Company Coordinates stock-summary
Company Details
Survey No 628 Temple Street, Jinnaram Mandal Bonthapally Medak Telangana : 502313
stock-summary
Tel: 91-8458-275236
stock-summary
info@phytochemindia.com
Registrar Details
Bigshare Services Pvt Ltd , 306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda, Hyderabad